| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $1.29B | +21.9% |
| Cost of Revenue | $234.6M | +21.0% |
| Gross Profit | $1.06B | +22.1% |
| R&D Expense | $336.8M | +7.0% |
| SG&A Expense | $277.7M | -1.3% |
| Operating Income | -$174.2M | +41.1% |
| Pre-tax Income | -$26.3M | +88.2% |
| Income Tax | $2.6M | +216.7% |
| Net Income | -$28.9M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $985.9M | -39.0% |
| Accounts Receivable | $28.0M | -0.7% |
| Current Assets | $6.31B | -5.4% |
| Total Assets | $9.18B | -4.7% |
| Current Liabilities | $4.06B | +8.2% |
| Long-term Debt | $914.0M | -50.3% |
| Total Liabilities | $5.04B | -9.1% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $278.8M | +48.5% |
| Capital Expenditures | $976K | -87.1% |
| Investing Cash Flow | -$409.4M | -257.9% |
| Financing Cash Flow | -$742.6M | -415.9% |
| Free Cash Flow | $277.8M | +54.2% |
| +87.1% |
| EPS (Basic) | -$0.27 | +87.2% |
| EPS (Diluted) | -$0.27 | +87.2% |
| Stockholders' Equity |
| $4.13B |
| +1.2% |